We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




DakoCytomation Acquires Gastric Ulcer Test

By HospiMedica staff writers
Posted on 15 Sep 2003
The rights to a test detecting the ulcer-causing bacteria Helicobactor pylori have been acquired by DakoCytomation (Copenhagen, Denmark) from Connex GmbH (Martinsried, Germany), a biotechnology company.

According to the agreement, DakoCytomation will handle continued production, sales, distribution, and customer service of the test, which will become part of DakoCytomation's diagnostic portfolio. More...
The H pylori antibodies are used in a test that is an enzyme-linked immunosorbent assay (ELISA). Compared to other tests, this method is noninvasive and because it is cost effective, more patients will be able to receive optimal treatment, states DakoCytomation.

"Acquisition of the H pylori rights is strategically important to us; we continuously aim at expanding and strengthening our proprietary pool of key intellectual property rights to better serve our customers and secure our continued development and growth,” said Erik Winther, executive vice president and CFO of DakoCytomation.





Related Links:
DakoCytomation
Connex

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.